We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Histone Deacetylase May Be a Novel Therapeutic Strategy for Lung Cancer

News   Mar 27, 2020 | Original story from the Moffitt Cancer Center

 
Histone Deacetylase May Be a Novel Therapeutic Strategy for Lung Cancer

Credit: iStock

 
 
Advertisement
 

RELATED ARTICLES

No More Needles for Diagnostic Tests?

News

Nearly pain-free microneedle patch can test for antibodies and more in the fluid between cells.

READ MORE

Maternal Autoantibodies Highly Associated With Diagnosis of Autism

News

Using machine learning, researchers at the UC Davis MIND Institute have identified several patterns of maternal autoantibodies highly associated with the diagnosis and severity of autism.

READ MORE

Preventing Chemotherapy From Damaging the Heart

News

Researchers have discovered that the chemotherapy drug doxorubicin is able to enter heart cells by hitchhiking on a specific type of protein that functions as a transporter to move drugs from the blood into heart cells. By introducing another anti-cancer drug in advance of the chemotherapy, the team was able to block the transporter protein.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE